Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | HCAR3 | P49019 | 3/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4295085 | 1.00 | MAPT (0.63) | MAPTKDM4EALDH1A1POLBKMT2A | |
| SCHEMBL29928397 | 1.00 | MAPT (0.63) | MAPTKDM4EALDH1A1POLBKMT2A | |
| SCHEMBL9755054 | 0.99 | MAPT (0.65) | MAPTKDM4EALDH1A1POLBKMT2A | |
| SCHEMBL4301793 | 0.95 | MAPT (0.70) | MAPTKDM4EALDH1A1POLBKMT2A | |
| SCHEMBL10932609 | 0.90 | MAPT (0.63) | MAPTKDM4EALDH1A1POLBKMT2A | |
| SCHEMBL7349997 | 0.89 | MAPT (0.62) | MAPTKDM4EALDH1A1POLBKMT2A | |
| SCHEMBL17875231 | 0.88 | MAPT (0.56) | MAPTKDM4EALDH1A1POLBKMT2A | |
| SCHEMBL27343040 | 0.86 | MAPT (0.73) | MAPTKDM4EALDH1A1POLBGAA | |
| SCHEMBL8536167 | 0.86 | PRSS1 (0.56) | MAPTKDM4EALDH1A1POLBKMT2A | |
| SCHEMBL14364287 | 0.85 | MAPT (0.60) | MAPTKDM4EALDH1A1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7881871-B2 | Method for designing surfaces | BIO-LAYER PTY LIMITED (AU) | 2011-02-01 | — | — | US | claimed |
| EP-1700244-A4 | A METHOD FOR DESIGNING SURFACES | BIO LAYER PTY LTD (AU) | 2009-07-08 | — | — | EP | claimed |
| US-20070099235-A1 | Method for designing surfaces | BIO-LAYER PTY LIMITED (AU) | 2007-05-03 | — | — | US | claimed |
| EP-1700244-A1 | A METHOD FOR DESIGNING SURFACES | Bio-Layer Pty Limited (AU) | 2006-09-13 | — | — | EP | claimed |
| WO-2005057462-A1 | A METHOD FOR DESIGNING SURFACES | BIO-LAYER PTY LIMITED (AU) | 2005-06-23 | — | — | WO | claimed |
| WO-2025129193-A1 | GLYCOSYLTRANSFERASES AND RELATED METHODS | NEW ENGLAND BIOLABS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| EP-3382039-B1 | METHODS FOR DETECTING NUCLEIC ACID SEQUENCE VARIANTS | BIOCEPT INC (US) | 2023-09-13 | — | — | EP | disclosed |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | NEW ENGLAND BIOLABS, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS SA (ES) | 2022-12-08 | — | — | US | disclosed |
| US-11479766-B2 | Methods for labeling a population of RNA molecules | NEW ENGLAND BIOLABS, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| US-20220017957-A1 | METHODS FOR DETECTING NUCLEIC ACID SEQUENCE VARIANTS | AEGEA BIOTECHNOLOGIES, INC. | 2022-01-20 | — | — | US | disclosed |
| US-11034991-B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | ORYZON GENOMICS S.A. (ES) | 2021-06-15 | — | — | US | disclosed |
| US-4366243-A | POLYVINYL ALCOHOL, ALBUMIN | MILES LABORATORIES, INC. (US) | 1982-12-28 | — | — | US | disclosed |
| US-4340668-A | Heme-labeled specific binding assay | MILES LABORATORIES, INC. (US) | 1982-07-20 | — | — | US | disclosed |
| EP-0051213-A1 | Homogeneous specific binding assay device, method for preparing it and analytical method using the device | MILES LABORATORIES, INC. (US) | 1982-05-12 | — | — | EP | disclosed |
| US-4318982-A | FMN-Labeled specific binding assay | MILES LABORATORIES, INC. (US) | 1982-03-09 | — | — | US | disclosed |
| US-4318983-A | Fad-labeled specific binding assay monitored with apoglutathione reductase or apolipoamide dehydrogenase | MILES LABORATORIES, INC. (US) | 1982-03-09 | — | — | US | disclosed |
| US-4255566-A | N6-(OMEGA-AMINOALKYL)ADENINE DINUCLEOTIDE DERIVATIVES; IMMUNOASSAY | MILES LABORATORIES (US) | 1981-03-10 | — | — | US | disclosed |
| US-4238565-A | Specific binding assay with a prosthetic group as a label component | MILES LABORATORIES, INC. (US) | 1980-12-09 | — | — | US | disclosed |
| US-4134792-A | Specific binding assay with an enzyme modulator as a labeling substance | MILES LABORATORIES, INC. (US) | 1979-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | KDM1B, KDM1A, KDM7A | MAPT 4545/4885KDM4E 22/4885ALDH1A1 1155/4885 |
| US-11479766-B2 | Methods for labeling a population of RNA molecules | RNGTT, RNMT, MTAP | MAPT 4076/4885KDM4E 1517/4885ALDH1A1 2357/4885 |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | RNGTT, RNMT, MTAP | MAPT 4076/4885KDM4E 1517/4885ALDH1A1 2357/4885 |
| US-11034991-B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | KDM1B, KDM1A, KDM7A | MAPT 4545/4885KDM4E 22/4885ALDH1A1 1155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.